Thomas Harth
Direktor/Vorstandsmitglied bei Tagworks Pharmaceuticals BV
Ursprung des Netzwerks ersten Grades von Thomas Harth
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Ghent University
35
| College/University | Other Consumer Services | 35 |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona.
18
| Private Company | Investment Managers | 18 |
Tagworks Pharmaceuticals BV
 Tagworks Pharmaceuticals BV BiotechnologyHealth Technology Tagworks Pharmaceuticals BV is a Dutch precision therapy company that develops a new standard of care for patients suffering from severe diseases, including cancer. Tagworks Pharmaceuticals is based in and the Netherlands. The company leverages its technology platform, which is protected by a broad patent estate, to pioneer the click-to-release approach. Tagworks is developing a pipeline of click-cleavable therapies, including its lead program, TGW101, an antibody-drug conjugate targeting TAG72. The company's technology enables on-target activation of ADCs and immunomodulators, as well as off-target deactivation of radioimmunotherapies to enhance their therapeutic index. The company was founded in 2011 by Raffaella Rossin, Zach Taylor, Marc Robillard, and Marc Robillard has been the CEO since 2011.
7
| Holding Company | Biotechnology | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Thomas Harth
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Participatiemaatschappij Vlaanderen NV
 Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor Director/Board Member Private Equity Investor | |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree Undergraduate Degree | |
| Universitat Pompeu Fabra | College/University | Graduate Degree Graduate Degree | |
Prexton Therapeutics SA
 Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Director/Board Member Founder | |
Medlumics SL
 Medlumics SL Medical SpecialtiesHealth Technology Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain. | Medical Specialties | Director/Board Member Director/Board Member | |
Inbiomotion SL
 Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Chairman Director/Board Member | |
| University of Nebraska Omaha | College/University | Masters Business Admin Masters Business Admin | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member Director/Board Member | |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
STAT-Dx Life SL
 STAT-Dx Life SL Medical SpecialtiesHealth Technology STAT-Dx Life SL focuses on the development, manufacturing and commercialization of diagnostic solutions for fast and accurate diagnostic results of infectious diseases and critical care. It solution offers DiagCORE Cartridge, for sample and analyzation of cell material, nucleic acid purification, amplification and hybridization process. The company was founded by Jordi Cabrrera Fabra and Rafael Bru Gibert in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Deusto | College/University | Masters Business Admin Masters Business Admin | |
| University of Barcelona | College/University | Doctorate Degree Undergraduate Degree | |
Roche Glycart AG
 Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Baltisse NV (Private Equity)
 Baltisse NV (Private Equity) Investment ManagersFinance Baltisse NV /Private Equity/ (Baltisse) is a private equity subsidiary of Baltisse NV founded in 2006. The firm is headquartered in Sint-Denijs-Westrem, Belgium. | Investment Managers | General Counsel Private Equity Investor | |
EQT Netherlands Management BV
 EQT Netherlands Management BV Investment ManagersFinance EQT Partners BV operates as a financial holding company with interests in providing investments. The company was founded on July 3, 2012 and is headquartered in Schiphol, the Netherlands. | Investment Managers | Private Equity Analyst Private Equity Investor | |
Holland Capital Management BV
 Holland Capital Management BV Investment ManagersFinance Holland Capital Management BV (Holland Capital) is an independent private equity & venture capital firm founded in 1981. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Waterland Private Equity NV | Investment Managers | Private Equity Investor General Counsel | |
LongeVC
 LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | Investment Managers | Founder | |
| European Parliament | General Government | Corporate Officer/Principal | |
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Aelix, Inc.
 Aelix, Inc. Internet Software/ServicesTechnology Services Part of Billing Services Group Ltd., Aelix, Inc. provides intelligent communications solutions to enterprises, notably in the travel and hospitality, financial services, and electronic commerce sectors. The company is based in Los Angeles, CA. Aelix was acquired by Avery Communications, Inc. from ComF5 International, Inc. on December 04, 2001 for $4.10 million. | Internet Software/Services | Director/Board Member | |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Aelix Therapeutics SL
 Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
CytoKi Pharma ApS
 CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services CytoKi Pharma ApS engages in the research and experimental development within biotechnology. It develops therapeutics for serious tissue and organ injuries. The company was founded by Rasmus Jørgensen on June 12, 2019 and is headquartered in Vaerlose, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Vortex Oil Engineering SIA
 Vortex Oil Engineering SIA Oilfield Services/EquipmentIndustrial Services Vortex Oil Engineering SIA produces and maintains the devices for increasing oil recovery from productive oil layers. Its technology is used in water flooding process. The company was founded by Sergey Jakimov and is headquartered in Riga, Latvia. | Oilfield Services/Equipment | Chief Executive Officer | |
| Solvay Business School of Economics & Management | College/University | Masters Business Admin | |
Koatum SIA
 Koatum SIA Medical SpecialtiesHealth Technology Koatum SIA provides implantable products of medical engineering, such as dental, orthopedic and reconstructive implants. The company was founded in 2014 and is headquartered in Jurmala, Latvia. | Medical Specialties | Corporate Officer/Principal | |
| UNIFIEDPOST GROUP SA | Packaged Software | Director/Board Member | |
Longenesis SIA
 Longenesis SIA Data Processing ServicesTechnology Services SIA Longenesis promotes collaboration between biomedical institutions, patient organizations, and research partners. The company is based in Riga, Latvia and has subsidiaries in Hong Kong. The Latvian company identifies biomedical data from metadata files, onboards population cohorts, and engages new patients in research. The company was founded by Garri Zmudze. | Data Processing Services | Director/Board Member | |
| Government of Belgium | Sovereign | Minister of Government | |
| Aphilion Q² SICAV | Investment Trusts/Mutual Funds | Chairman | |
Dexia SA (France)
 Dexia SA (France) Regional BanksFinance Dexia SA specializes in public and project financing. It provides retail and commercial banking services to individuals and SMEs, asset management, and insurance sectors. The company is headquartered in Paris, France. | Regional Banks | Director/Board Member | |
| DEXIA HOLDING | Major Banks | Director/Board Member | |
| BlackFin Capital Partners Belgium SA | Investment Managers | Private Equity Analyst | |
Eshgro BV
 Eshgro BV Information Technology ServicesTechnology Services Eshgro BV provides information and communications technology services. It offers online desktop, telephony and printing services. The firm hosts and manages office automatisation, client and branch specific solutions on its multi-enterprise platform. The company was founded by Anton Loeffen in 1997 and is headquartered in Boxmeer, the Netherlands. | Information Technology Services | Chairman | |
| Central European University | College/University | Graduate Degree | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
| Riga Stradinš University | College/University | Undergraduate Degree | |
WPEF VII Holdco II BE NV
 WPEF VII Holdco II BE NV Financial ConglomeratesFinance WPEF VII Holdco II BE NV is an investment services company founded in 2019. The private company is based in Olen, Belgium. The Belgian company provides investment services. | Financial Conglomerates | Director/Board Member | |
| Riga Graduate School of Law | College/University | Graduate Degree | |
Xeltis AG
 Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Medical Specialties | Director/Board Member | |
| The University of Colorado School of Medicine | College/University | Doctorate Degree | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member |
Statistik
International
| Spanien | 13 |
| Belgien | 12 |
| Vereinigte Staaten | 7 |
| Niederlande | 6 |
| Schweiz | 5 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 12 |
| Finance | 11 |
| Technology Services | 5 |
| Government | 3 |
Operativ
| Director/Board Member | 138 |
| Graduate Degree | 52 |
| Corporate Officer/Principal | 51 |
| Private Equity Investor | 42 |
| Undergraduate Degree | 36 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Cristina Garmendia Mendizábal | 38 |
| Peter Andersen | 26 |
| Pamela Klein | 19 |
| Christopher Martin | 18 |
| Joël Jean-Mairet | 17 |
| Karen Wagner | 17 |
| Antoni Ribas | 15 |
| Edwin de Graaf | 14 |
| Carlos Paya | 14 |
| David Lacey | 12 |
| Sergey Jakimov | 8 |
| Lance Berman | 8 |
| Christina Isacson | 8 |
| Raúl Martín Ruiz | 8 |
| Michele Park | 8 |
- Börse
- Insiders
- Thomas Harth
- Unternehmensverbindungen
